90 participants
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-18
- Start Date:
- 2025-03-30
- Completion:
- 2032-03-12
Conditions
- Non-small Cell Lung Cancer
Interventions
- BIOLOGICAL
- DRUG
No Results Yet